Recommended Dosing for Streptomycin and Moxifloxacin in Pulmonary TB
For adults with pulmonary tuberculosis, streptomycin should be dosed at 15 mg/kg daily (or 25 mg/kg three times weekly), and moxifloxacin at 400 mg daily. 1, 2, 3
Streptomycin Dosing
Standard Adult Dosing
- Daily regimen: 15 mg/kg intramuscularly once daily (maximum 1 gram) 1, 2
- Intermittent regimen: 25-30 mg/kg three times weekly (maximum 1.5 grams per dose) 1, 2
- Some clinicians prefer the three times weekly dosing at 25 mg/kg 1
Critical Dosing Adjustments
- Patients >60 years old: Use reduced dosing due to increased toxicity risk; the 15 mg/kg dose should be given only three times weekly 1, 2
- Renal impairment: Reduce frequency to 2-3 times weekly with the 15 mg/kg dose to allow drug clearance 1
- Maximum cumulative dose: Do not exceed 120 grams total over the entire treatment course unless no other therapeutic options exist 2
Administration Details
- Administer via intramuscular injection only 2
- Preferred injection site: upper outer quadrant of buttock (gluteus maximus) or mid-lateral thigh 2
- Rotate injection sites and aspirate before injection to avoid inadvertent intravascular administration 2
Moxifloxacin Dosing
Standard Adult Dosing
- 400 mg once daily (oral or intravenous) 1, 3
- This dose applies whether used for drug-susceptible or drug-resistant TB 1
- No intermittent dosing: Inadequate data support twice-weekly or thrice-weekly administration 1
Administration Considerations
- Can be taken with or without food 3
- Critical drug interaction: Administer at least 4 hours before or 8 hours after products containing magnesium, aluminum, iron, or zinc (antacids, multivitamins, sucralfate) 3
- When switching from IV to oral formulation, no dose adjustment is necessary 3
Clinical Context and Evidence Quality
The dosing recommendations come from the 2016 ATS/CDC/IDSA guidelines for drug-susceptible TB 1 and the 2019 ATS/CDC/ERS/IDSA guidelines for drug-resistant TB 1, which represent the highest quality guideline evidence available. The FDA labeling for both drugs 2, 3 confirms these dosing recommendations.
When to Use These Agents
- Streptomycin: Added to standard regimens when drug resistance is suspected or proven 2
- Moxifloxacin: Used as a substitute drug in drug-susceptible TB or as part of regimens for drug-resistant TB 1
Common Pitfalls to Avoid
- Do not use streptomycin at full daily doses in elderly patients without dose reduction or frequency adjustment—ototoxicity risk is substantially elevated 1, 2
- Do not co-administer moxifloxacin with multivalent cations without appropriate time separation—this dramatically reduces absorption 3
- Monitor for moxifloxacin-related adverse events: Nausea occurs in approximately 22% of patients, though most complete therapy 4
- Therapeutic drug monitoring may be warranted for obese patients, as optimal dosing has not been established in this population 1
Renal Function Monitoring
Both drugs require careful attention to renal function. Streptomycin clearance is significantly affected by renal impairment, necessitating dose frequency reduction 1, 2. Moxifloxacin requires no dose adjustment for mild to moderate renal insufficiency, but use with caution in severe insufficiency 1.